世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

医療用超高純度酸素の世界市場成長 2023-2029


Global Medical Ultra-high Purity Oxygen Market Growth 2023-2029

LPI（LPインフォメーション）の最新調査によると、世界の医療用超高純度酸素市場規模は2022年に100万米ドルと評価されました。川下市場での需要拡大に伴い、医療用超高純度酸素の市場規模は2029年までに100万米ド... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション 		2023年10月30日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		101 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

LPI（LPインフォメーション）の最新調査によると、世界の医療用超高純度酸素市場規模は2022年に100万米ドルと評価されました。川下市場での需要拡大に伴い、医療用超高純度酸素の市場規模は2029年までに100万米ドルに再調整され、レビュー期間中の年平均成長率は%になると予測されています。
この調査レポートは、世界の医療用超高純度酸素市場の成長可能性を明らかにしています。医療用超高純度酸素は今後の市場でも安定した成長が見込まれる。しかし、医療用超高純度酸素の普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要です。医療用超高純度酸素市場がもたらす莫大なビジネスチャンスを生かすため、市場関係者は研究開発への投資、戦略的パートナーシップの構築、進化する消費者の嗜好に合わせた製品提供を行う必要がある。
医療用酸素濃度は、以下の3点を考慮し、規制に従って99.5%以上でなければならない：第一に、緊急時には患者の命を救うために高純度酸素を使用できること、第二に、高濃度酸素は臨床使用時に必要に応じて希釈できることである。3つ目は、濃度が高ければ高いほど、ガス中の雑誌の量が少なくなり、患者にとって安全であることである。
当社の調査によると、医療機器の世界市場は2023年に6,030億米ドルと推定され、今後6年間は年平均成長率5％で成長する。世界の医療支出は世界GDPの10％を占め、高齢化による健康ニーズの増加、慢性疾患や感染症の流行、新興市場の拡大により、近年増加の一途をたどっています。医療機器市場は、ヘルスケア産業において重要な役割を果たしている。同市場は、世界的な高度医療サービスに対する需要の増加、医療技術の進歩、高齢者人口の増加、医療費の増加、病気の早期診断と治療に対する意識の高まりなど、いくつかの要因によって牽引されている。
主な特徴
この調査レポートは、医療用超高純度酸素市場の様々な側面を反映し、業界に関する貴重な洞察を提供しています。
市場規模と成長：この調査レポートは、医療用超高純度酸素市場の現在の規模と成長の概要を提供しています。過去のデータ、タイプ別（99.5%-99.995%、>99.995%など）の市場区分、地域別の内訳などが含まれます。
市場促進要因と課題：政府規制、環境問題、技術進歩、消費者の嗜好の変化など、医療用超高純度酸素市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができます。
競合情勢：この調査レポートは、医療用超高純度酸素市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれています。また、新興企業やその市場に与える潜在的な影響にもスポットを当てることができます。
技術開発：この調査レポートは、医療用超高純度酸素産業における最新の技術開発を掘り下げることができます。これには医療用超高純度酸素技術の進歩、医療用超高純度酸素の新規参入、医療用超高純度酸素の新規投資、医療用超高純度酸素の将来を形作るその他の技術革新が含まれます。
川下企業の好み：医療用超高純度酸素市場における顧客の購買行動や採用動向を明らかにします。医療用超高純度酸素製品に対する顧客の購買決定や嗜好に影響を与える要因も含まれています。
政府の政策とインセンティブこの調査レポートは、医療用超高純度酸素市場に対する政府の政策やインセンティブの影響を分析しています。これには、医療用超高純度酸素市場の促進を目的とした規制枠組み、補助金、税制優遇措置などの評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性当調査レポートでは、医療用超高純度酸素市場の環境への影響と持続可能性の側面を評価しています。
市場予測と将来展望：当調査レポートでは、実施した分析に基づいて、医療用超高純度酸素産業の市場予測と展望を提供しています。これには市場規模、成長率、地域別動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートでは最後に、業界関係者、政策立案者、投資家への提言を行っています。市場関係者が新たなトレンドを活用し、課題を克服し、医療用超高純度酸素市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
医療用超高純度酸素市場はタイプ別と用途別に分類される。2018-2029年の期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。
タイプ別セグメント
99.5%-99.995%
＞99.995%
用途別セグメント
応急手当
高気圧酸素療法
その他
また、本レポートでは地域別に市場を分割しています：
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
リンデ・グループ
エアリキード
プラクセア
エアプロダクト
大陽日酸
エアガス
メッサー
エア・ウォーター
インデガス
杭州杭陽
SCGC
宝鋼ガス
広東省Huate Gas
本レポートで扱う主な質問
世界の医療用超高純度酸素市場の10年展望は？
医療用超高純度酸素市場の成長を促進する世界および地域別の要因は何か？
市場別・地域別に最も急成長する技術は何か？
医療用超高純度酸素の市場機会は最終市場規模によってどのように異なるのか？
医療用超高純度酸素のタイプ別、用途別内訳は？


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Ultra-high Purity Oxygen Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Medical Ultra-high Purity Oxygen by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Medical Ultra-high Purity Oxygen by Country/Region, 2018, 2022 & 2029
2.2 Medical Ultra-high Purity Oxygen Segment by Type
2.2.1 99.5%-99.995%
2.2.2 ＞99.995%
2.3 Medical Ultra-high Purity Oxygen Sales by Type
2.3.1 Global Medical Ultra-high Purity Oxygen Sales Market Share by Type (2018-2023)
2.3.2 Global Medical Ultra-high Purity Oxygen Revenue and Market Share by Type (2018-2023)
2.3.3 Global Medical Ultra-high Purity Oxygen Sale Price by Type (2018-2023)
2.4 Medical Ultra-high Purity Oxygen Segment by Application
2.4.1 First Aid
2.4.2 Hyperbaric Oxygen Therapy
2.4.3 Others
2.5 Medical Ultra-high Purity Oxygen Sales by Application
2.5.1 Global Medical Ultra-high Purity Oxygen Sale Market Share by Application (2018-2023)
2.5.2 Global Medical Ultra-high Purity Oxygen Revenue and Market Share by Application (2018-2023)
2.5.3 Global Medical Ultra-high Purity Oxygen Sale Price by Application (2018-2023)
3 Global Medical Ultra-high Purity Oxygen by Company
3.1 Global Medical Ultra-high Purity Oxygen Breakdown Data by Company
3.1.1 Global Medical Ultra-high Purity Oxygen Annual Sales by Company (2018-2023)
3.1.2 Global Medical Ultra-high Purity Oxygen Sales Market Share by Company (2018-2023)
3.2 Global Medical Ultra-high Purity Oxygen Annual Revenue by Company (2018-2023)
3.2.1 Global Medical Ultra-high Purity Oxygen Revenue by Company (2018-2023)
3.2.2 Global Medical Ultra-high Purity Oxygen Revenue Market Share by Company (2018-2023)
3.3 Global Medical Ultra-high Purity Oxygen Sale Price by Company
3.4 Key Manufacturers Medical Ultra-high Purity Oxygen Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Ultra-high Purity Oxygen Product Location Distribution
3.4.2 Players Medical Ultra-high Purity Oxygen Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical Ultra-high Purity Oxygen by Geographic Region
4.1 World Historic Medical Ultra-high Purity Oxygen Market Size by Geographic Region (2018-2023)
4.1.1 Global Medical Ultra-high Purity Oxygen Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Medical Ultra-high Purity Oxygen Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Medical Ultra-high Purity Oxygen Market Size by Country/Region (2018-2023)
4.2.1 Global Medical Ultra-high Purity Oxygen Annual Sales by Country/Region (2018-2023)
4.2.2 Global Medical Ultra-high Purity Oxygen Annual Revenue by Country/Region (2018-2023)
4.3 Americas Medical Ultra-high Purity Oxygen Sales Growth
4.4 APAC Medical Ultra-high Purity Oxygen Sales Growth
4.5 Europe Medical Ultra-high Purity Oxygen Sales Growth
4.6 Middle East & Africa Medical Ultra-high Purity Oxygen Sales Growth
5 Americas
5.1 Americas Medical Ultra-high Purity Oxygen Sales by Country
5.1.1 Americas Medical Ultra-high Purity Oxygen Sales by Country (2018-2023)
5.1.2 Americas Medical Ultra-high Purity Oxygen Revenue by Country (2018-2023)
5.2 Americas Medical Ultra-high Purity Oxygen Sales by Type
5.3 Americas Medical Ultra-high Purity Oxygen Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Ultra-high Purity Oxygen Sales by Region
6.1.1 APAC Medical Ultra-high Purity Oxygen Sales by Region (2018-2023)
6.1.2 APAC Medical Ultra-high Purity Oxygen Revenue by Region (2018-2023)
6.2 APAC Medical Ultra-high Purity Oxygen Sales by Type
6.3 APAC Medical Ultra-high Purity Oxygen Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Ultra-high Purity Oxygen by Country
7.1.1 Europe Medical Ultra-high Purity Oxygen Sales by Country (2018-2023)
7.1.2 Europe Medical Ultra-high Purity Oxygen Revenue by Country (2018-2023)
7.2 Europe Medical Ultra-high Purity Oxygen Sales by Type
7.3 Europe Medical Ultra-high Purity Oxygen Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Ultra-high Purity Oxygen by Country
8.1.1 Middle East & Africa Medical Ultra-high Purity Oxygen Sales by Country (2018-2023)
8.1.2 Middle East & Africa Medical Ultra-high Purity Oxygen Revenue by Country (2018-2023)
8.2 Middle East & Africa Medical Ultra-high Purity Oxygen Sales by Type
8.3 Middle East & Africa Medical Ultra-high Purity Oxygen Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Ultra-high Purity Oxygen
10.3 Manufacturing Process Analysis of Medical Ultra-high Purity Oxygen
10.4 Industry Chain Structure of Medical Ultra-high Purity Oxygen
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Ultra-high Purity Oxygen Distributors
11.3 Medical Ultra-high Purity Oxygen Customer
12 World Forecast Review for Medical Ultra-high Purity Oxygen by Geographic Region
12.1 Global Medical Ultra-high Purity Oxygen Market Size Forecast by Region
12.1.1 Global Medical Ultra-high Purity Oxygen Forecast by Region (2024-2029)
12.1.2 Global Medical Ultra-high Purity Oxygen Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Ultra-high Purity Oxygen Forecast by Type
12.7 Global Medical Ultra-high Purity Oxygen Forecast by Application
13 Key Players Analysis
13.1 Linde Group
13.1.1 Linde Group Company Information
13.1.2 Linde Group Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.1.3 Linde Group Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Linde Group Main Business Overview
13.1.5 Linde Group Latest Developments
13.2 AirLiquide
13.2.1 AirLiquide Company Information
13.2.2 AirLiquide Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.2.3 AirLiquide Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AirLiquide Main Business Overview
13.2.5 AirLiquide Latest Developments
13.3 Praxair
13.3.1 Praxair Company Information
13.3.2 Praxair Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.3.3 Praxair Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Praxair Main Business Overview
13.3.5 Praxair Latest Developments
13.4 Air Product
13.4.1 Air Product Company Information
13.4.2 Air Product Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.4.3 Air Product Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Air Product Main Business Overview
13.4.5 Air Product Latest Developments
13.5 Taiyo Nippon Sanso
13.5.1 Taiyo Nippon Sanso Company Information
13.5.2 Taiyo Nippon Sanso Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.5.3 Taiyo Nippon Sanso Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Taiyo Nippon Sanso Main Business Overview
13.5.5 Taiyo Nippon Sanso Latest Developments
13.6 Airgas
13.6.1 Airgas Company Information
13.6.2 Airgas Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.6.3 Airgas Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Airgas Main Business Overview
13.6.5 Airgas Latest Developments
13.7 MESSER
13.7.1 MESSER Company Information
13.7.2 MESSER Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.7.3 MESSER Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MESSER Main Business Overview
13.7.5 MESSER Latest Developments
13.8 Air Water
13.8.1 Air Water Company Information
13.8.2 Air Water Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.8.3 Air Water Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Air Water Main Business Overview
13.8.5 Air Water Latest Developments
13.9 Yingde Gases
13.9.1 Yingde Gases Company Information
13.9.2 Yingde Gases Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.9.3 Yingde Gases Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Yingde Gases Main Business Overview
13.9.5 Yingde Gases Latest Developments
13.10 Hangzhou Hangyang
13.10.1 Hangzhou Hangyang Company Information
13.10.2 Hangzhou Hangyang Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.10.3 Hangzhou Hangyang Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hangzhou Hangyang Main Business Overview
13.10.5 Hangzhou Hangyang Latest Developments
13.11 SCGC
13.11.1 SCGC Company Information
13.11.2 SCGC Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.11.3 SCGC Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 SCGC Main Business Overview
13.11.5 SCGC Latest Developments
13.12 Baosteel Gases
13.12.1 Baosteel Gases Company Information
13.12.2 Baosteel Gases Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.12.3 Baosteel Gases Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Baosteel Gases Main Business Overview
13.12.5 Baosteel Gases Latest Developments
13.13 Guangdong Huate Gas
13.13.1 Guangdong Huate Gas Company Information
13.13.2 Guangdong Huate Gas Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.13.3 Guangdong Huate Gas Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Guangdong Huate Gas Main Business Overview
13.13.5 Guangdong Huate Gas Latest Developments
14 Research Findings and Conclusion

　

ページTOPに戻る


　

Summary

According to our LPI (LP Information) latest study, the global Medical Ultra-high Purity Oxygen market size was valued at US$ million in 2022. With growing demand in downstream market, the Medical Ultra-high Purity Oxygen is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Medical Ultra-high Purity Oxygen market. Medical Ultra-high Purity Oxygen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Medical Ultra-high Purity Oxygen. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Medical Ultra-high Purity Oxygen market.
The medical oxygen concentration should be above 99.5% according to the regulations, based on the following three considerations: First, in emergency state, high-purity oxygen can be used to save the patient's life; second, high-concentration oxygen can be diluted as needed for clinical use. The required oxygen concentration is used for treatment; the third is that the higher the concentration, the smaller the amount of magazine in the gas, and the safer it is for the patient.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Medical Ultra-high Purity Oxygen market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Medical Ultra-high Purity Oxygen market. It may include historical data, market segmentation by Type (e.g., 99.5%-99.995%, ＞99.995%), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Medical Ultra-high Purity Oxygen market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Medical Ultra-high Purity Oxygen market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Medical Ultra-high Purity Oxygen industry. This include advancements in Medical Ultra-high Purity Oxygen technology, Medical Ultra-high Purity Oxygen new entrants, Medical Ultra-high Purity Oxygen new investment, and other innovations that are shaping the future of Medical Ultra-high Purity Oxygen.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Medical Ultra-high Purity Oxygen market. It includes factors influencing customer ' purchasing decisions, preferences for Medical Ultra-high Purity Oxygen product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Medical Ultra-high Purity Oxygen market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Medical Ultra-high Purity Oxygen market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Medical Ultra-high Purity Oxygen market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Medical Ultra-high Purity Oxygen industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Medical Ultra-high Purity Oxygen market.
Market Segmentation:
Medical Ultra-high Purity Oxygen market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
99.5%-99.995%
＞99.995%
Segmentation by application
First Aid
Hyperbaric Oxygen Therapy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Linde Group
AirLiquide
Praxair
Air Product
Taiyo Nippon Sanso
Airgas
MESSER
Air Water
Yingde Gases
Hangzhou Hangyang
SCGC
Baosteel Gases
Guangdong Huate Gas
Key Questions Addressed in this Report
What is the 10-year outlook for the global Medical Ultra-high Purity Oxygen market?
What factors are driving Medical Ultra-high Purity Oxygen market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Ultra-high Purity Oxygen market opportunities vary by end market size?
How does Medical Ultra-high Purity Oxygen break out type, application?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Ultra-high Purity Oxygen Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Medical Ultra-high Purity Oxygen by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Medical Ultra-high Purity Oxygen by Country/Region, 2018, 2022 & 2029
2.2 Medical Ultra-high Purity Oxygen Segment by Type
2.2.1 99.5%-99.995%
2.2.2 ＞99.995%
2.3 Medical Ultra-high Purity Oxygen Sales by Type
2.3.1 Global Medical Ultra-high Purity Oxygen Sales Market Share by Type (2018-2023)
2.3.2 Global Medical Ultra-high Purity Oxygen Revenue and Market Share by Type (2018-2023)
2.3.3 Global Medical Ultra-high Purity Oxygen Sale Price by Type (2018-2023)
2.4 Medical Ultra-high Purity Oxygen Segment by Application
2.4.1 First Aid
2.4.2 Hyperbaric Oxygen Therapy
2.4.3 Others
2.5 Medical Ultra-high Purity Oxygen Sales by Application
2.5.1 Global Medical Ultra-high Purity Oxygen Sale Market Share by Application (2018-2023)
2.5.2 Global Medical Ultra-high Purity Oxygen Revenue and Market Share by Application (2018-2023)
2.5.3 Global Medical Ultra-high Purity Oxygen Sale Price by Application (2018-2023)
3 Global Medical Ultra-high Purity Oxygen by Company
3.1 Global Medical Ultra-high Purity Oxygen Breakdown Data by Company
3.1.1 Global Medical Ultra-high Purity Oxygen Annual Sales by Company (2018-2023)
3.1.2 Global Medical Ultra-high Purity Oxygen Sales Market Share by Company (2018-2023)
3.2 Global Medical Ultra-high Purity Oxygen Annual Revenue by Company (2018-2023)
3.2.1 Global Medical Ultra-high Purity Oxygen Revenue by Company (2018-2023)
3.2.2 Global Medical Ultra-high Purity Oxygen Revenue Market Share by Company (2018-2023)
3.3 Global Medical Ultra-high Purity Oxygen Sale Price by Company
3.4 Key Manufacturers Medical Ultra-high Purity Oxygen Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Ultra-high Purity Oxygen Product Location Distribution
3.4.2 Players Medical Ultra-high Purity Oxygen Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical Ultra-high Purity Oxygen by Geographic Region
4.1 World Historic Medical Ultra-high Purity Oxygen Market Size by Geographic Region (2018-2023)
4.1.1 Global Medical Ultra-high Purity Oxygen Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Medical Ultra-high Purity Oxygen Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Medical Ultra-high Purity Oxygen Market Size by Country/Region (2018-2023)
4.2.1 Global Medical Ultra-high Purity Oxygen Annual Sales by Country/Region (2018-2023)
4.2.2 Global Medical Ultra-high Purity Oxygen Annual Revenue by Country/Region (2018-2023)
4.3 Americas Medical Ultra-high Purity Oxygen Sales Growth
4.4 APAC Medical Ultra-high Purity Oxygen Sales Growth
4.5 Europe Medical Ultra-high Purity Oxygen Sales Growth
4.6 Middle East & Africa Medical Ultra-high Purity Oxygen Sales Growth
5 Americas
5.1 Americas Medical Ultra-high Purity Oxygen Sales by Country
5.1.1 Americas Medical Ultra-high Purity Oxygen Sales by Country (2018-2023)
5.1.2 Americas Medical Ultra-high Purity Oxygen Revenue by Country (2018-2023)
5.2 Americas Medical Ultra-high Purity Oxygen Sales by Type
5.3 Americas Medical Ultra-high Purity Oxygen Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Ultra-high Purity Oxygen Sales by Region
6.1.1 APAC Medical Ultra-high Purity Oxygen Sales by Region (2018-2023)
6.1.2 APAC Medical Ultra-high Purity Oxygen Revenue by Region (2018-2023)
6.2 APAC Medical Ultra-high Purity Oxygen Sales by Type
6.3 APAC Medical Ultra-high Purity Oxygen Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Ultra-high Purity Oxygen by Country
7.1.1 Europe Medical Ultra-high Purity Oxygen Sales by Country (2018-2023)
7.1.2 Europe Medical Ultra-high Purity Oxygen Revenue by Country (2018-2023)
7.2 Europe Medical Ultra-high Purity Oxygen Sales by Type
7.3 Europe Medical Ultra-high Purity Oxygen Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Ultra-high Purity Oxygen by Country
8.1.1 Middle East & Africa Medical Ultra-high Purity Oxygen Sales by Country (2018-2023)
8.1.2 Middle East & Africa Medical Ultra-high Purity Oxygen Revenue by Country (2018-2023)
8.2 Middle East & Africa Medical Ultra-high Purity Oxygen Sales by Type
8.3 Middle East & Africa Medical Ultra-high Purity Oxygen Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Ultra-high Purity Oxygen
10.3 Manufacturing Process Analysis of Medical Ultra-high Purity Oxygen
10.4 Industry Chain Structure of Medical Ultra-high Purity Oxygen
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Ultra-high Purity Oxygen Distributors
11.3 Medical Ultra-high Purity Oxygen Customer
12 World Forecast Review for Medical Ultra-high Purity Oxygen by Geographic Region
12.1 Global Medical Ultra-high Purity Oxygen Market Size Forecast by Region
12.1.1 Global Medical Ultra-high Purity Oxygen Forecast by Region (2024-2029)
12.1.2 Global Medical Ultra-high Purity Oxygen Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Ultra-high Purity Oxygen Forecast by Type
12.7 Global Medical Ultra-high Purity Oxygen Forecast by Application
13 Key Players Analysis
13.1 Linde Group
13.1.1 Linde Group Company Information
13.1.2 Linde Group Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.1.3 Linde Group Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Linde Group Main Business Overview
13.1.5 Linde Group Latest Developments
13.2 AirLiquide
13.2.1 AirLiquide Company Information
13.2.2 AirLiquide Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.2.3 AirLiquide Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AirLiquide Main Business Overview
13.2.5 AirLiquide Latest Developments
13.3 Praxair
13.3.1 Praxair Company Information
13.3.2 Praxair Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.3.3 Praxair Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Praxair Main Business Overview
13.3.5 Praxair Latest Developments
13.4 Air Product
13.4.1 Air Product Company Information
13.4.2 Air Product Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.4.3 Air Product Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Air Product Main Business Overview
13.4.5 Air Product Latest Developments
13.5 Taiyo Nippon Sanso
13.5.1 Taiyo Nippon Sanso Company Information
13.5.2 Taiyo Nippon Sanso Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.5.3 Taiyo Nippon Sanso Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Taiyo Nippon Sanso Main Business Overview
13.5.5 Taiyo Nippon Sanso Latest Developments
13.6 Airgas
13.6.1 Airgas Company Information
13.6.2 Airgas Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.6.3 Airgas Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Airgas Main Business Overview
13.6.5 Airgas Latest Developments
13.7 MESSER
13.7.1 MESSER Company Information
13.7.2 MESSER Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.7.3 MESSER Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MESSER Main Business Overview
13.7.5 MESSER Latest Developments
13.8 Air Water
13.8.1 Air Water Company Information
13.8.2 Air Water Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.8.3 Air Water Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Air Water Main Business Overview
13.8.5 Air Water Latest Developments
13.9 Yingde Gases
13.9.1 Yingde Gases Company Information
13.9.2 Yingde Gases Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.9.3 Yingde Gases Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Yingde Gases Main Business Overview
13.9.5 Yingde Gases Latest Developments
13.10 Hangzhou Hangyang
13.10.1 Hangzhou Hangyang Company Information
13.10.2 Hangzhou Hangyang Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.10.3 Hangzhou Hangyang Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hangzhou Hangyang Main Business Overview
13.10.5 Hangzhou Hangyang Latest Developments
13.11 SCGC
13.11.1 SCGC Company Information
13.11.2 SCGC Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.11.3 SCGC Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 SCGC Main Business Overview
13.11.5 SCGC Latest Developments
13.12 Baosteel Gases
13.12.1 Baosteel Gases Company Information
13.12.2 Baosteel Gases Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.12.3 Baosteel Gases Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Baosteel Gases Main Business Overview
13.12.5 Baosteel Gases Latest Developments
13.13 Guangdong Huate Gas
13.13.1 Guangdong Huate Gas Company Information
13.13.2 Guangdong Huate Gas Medical Ultra-high Purity Oxygen Product Portfolios and Specifications
13.13.3 Guangdong Huate Gas Medical Ultra-high Purity Oxygen Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Guangdong Huate Gas Main Business Overview
13.13.5 Guangdong Huate Gas Latest Developments
14 Research Findings and Conclusion

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（ケミカル）の最新刊レポート

LP Information社の化学材料分野での最新刊レポート

本レポートと同じKEY WORD（oxygen）の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15　10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.